Farnesoid X receptor (FXR) as a potential therapeutic target in nonalcoholic fatty liver disease and associated syndromes

por Apollinariya V. Bogolyubova, Alexander Y. Mayorov, Ekaterina E. Mishina, Anton M. Schwartz, Pavel V. Belousov
Publicado 2017

Association of insulin resistance and non-alcoholic fatty liver disease

por Ekaterina E. Mishina, Alexander Y. Mayorov, Pavel O. Bogomolov, Ekaterina O. Liusina, Alexey O. Bueverov
Publicado 2021

Assessment the equivalence of the bioanalogue insulin lizpro biphasic 25 (Geropharm-bio, Russia) and Humalog® Mix 25 (Lilly France, France) using the euglycemic hyperinsulinum clam...

por Alexander Y. Mayorov, Ekaterina O. Koksharova, Ekaterina E. Mishina, Roman V. Drai, Olga I. Avdeeva, Igor E. Makarenko
Publicado 2018

Nonalcoholic fatty liver disease: cause or consequence of insulin resistance?

por Ekaterina E. Mishina, Alexander Y. Mayorov, Pavel O. Bogomolov, Maria V. Matsievich, Ksenia Y. Kokina, Apollinariya V. Bogolyubova
Publicado 2017

Influence of hyperinsulinemic – hypoglycemic clamp on induced platelet aggregation, activity of physiological anticoagulants and von Willebrand factor in patients with type I diabe...

por Iwona R. Jarek-Martynowa, Mikhail Y. Martynov, Karina G. Sarkisova, Ekaterina O. Koksharova, Ekaterina E. Mishina, Albina N. Yasamanova, Marina V. Shestakova
Publicado 2018